IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients

Journal of Neuroimmunology

Volumn 290, Issue , 2016, Pages 22-25

  Mendieta, Danelia ^a   la Cruz Aguilera, Dora Luz De ^b   Barrera Villalpando, Maria Isabel ^a   Becerril Villanueva, Enrique ^a   Arreola, Rodrigo ^a   Hernández Ferreira, Erick ^a   Pérez Tapia, Sonia Mayra ^c   Pérez Sánchez, Gilberto ^a   Garcés Alvarez, María Eugenia ^a,c   Aguirre Cruz, Lucinda ^b   Velasco Velázquez, Marco Antonio ^d   Pavón, Lenin ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Fibromyalgia; FIQ; IL 6; IL 8; Inflammation

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; AUTACOID; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BLOOD SAMPLING; CHRONIC PAIN; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; MIDDLE AGED; QUESTIONNAIRE;

ADULT; BIOMARKERS; FEMALE; FIBROMYALGIA; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES;

EID: 84955156152     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.11.011     Document Type: Article

References (32)

1. Arnold L.M., Clauw D.J., McCarberg B.H. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin. Proc. 2011, 86(5):457-464.
2. Bazzichi L., Rossi A., Massimetti G., Giannaccini G., Giuliano T., De Feo F., et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin. Exp. Rheumatol. 2007, 25(2):225-230.
3. Behm F.G., Gavin I.M., Karpenko O., Lindgren V., Gaitonde S., Gashkoff P.A., et al. Unique immunologic patterns in fibromyalgia. BMC Clin. Pathol. 2012, 12:25.
4. Bote M.E., Garcia J.J., Hinchado M.D., Ortega E. Inflammatory/stress feedback dysregulation in women with fibromyalgia. Neuroimmunomodulation 2012, 19(6):343-351.
5. Bote M.E., Garcia J.J., Hinchado M.D., Ortega E. Fibromyalgia: anti-inflammatory and stress responses after acute moderate exercise. PLoS One 2013, 8(9):e74524.
6. Bradley L.A. Pathophysiology of fibromyalgia. Am. J. Med. 2009, 122(12 Suppl):S22-S30.
7. Cunha F.Q., Lorenzetti B.B., Poole S., Ferreira S.H. Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol. 1991, 104(3):765-767.
8. Galindo Vázquez O., Rojas Castillo E., Meneses García A., Aguilar Ponce J.L., Álvarez Avitia M.Á., Alvarado Aguilar S. Propiedades Psicométricas del Inventario de Ansiedad de Beck (BAI) en Pacientes con Cáncer 2015.
9. Garcia J.J., Cidoncha A., Bote M.E., Hinchado M.D., Ortega E. Altered profile of chemokines in fibromyalgia patients. Ann. Clin. Biochem. 2014, 51(Pt 5):576-581.
10. Geiss A., Rohleder N., Anton F. Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia. Psychoneuroendocrinology 2012, 37(5):671-684.
11. Gupta D., Morley J.E. Hypothalamic-pituitary-adrenal (HPA) axis and aging. Compr. Physiol. 2014, 4(4):1495-1510.
12. Hernandez M.E., Becerril E., Perez M., Leff P., Anton B., Estrada S., et al. Proinflammatory cytokine levels in fibromyalgia patients are independent of body mass index. BMC Res. Notes 2010, 3(1):156.
13. Imamura M., Targino R.A., Hsing W.T., Imamura S., Azevedo R.S., Boas L.S., et al. Concentration of cytokines in patients with osteoarthritis of the knee and fibromyalgia. Clin. Interv. Aging 2014, 9:939-944.
14. Jay G.W., Barkin R.L. Fibromyalgia. Dis. Mon. 2015, 61(3):66-111.
15. Jurado S., Villegas M.E., Méndez L., Rodríguez F., Loperena V., Varela R. La estandarización del inventario de depresión de beck pata los residentes de la ciudad de Mexico. Salud Ment. 1998, 21(3):26-31.
16. Kadetoff D., Lampa J., Westman M., Andersson M., Kosek E. Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J. Neuroimmunol. 2012, 242(1-2):33-38.
17. Kosek E., Altawil R., Kadetoff D., Finn A., Westman M., Le Maitre E., et al. Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain-interleukin-8 in fibromyalgia and interleukin-1 beta in rheumatoid arthritis. J. Neuroimmunol. 2015, 280:49-55.
18. Malek H., Ebadzadeh M.M., Safabakhsh R., Razavi A., Zaringhalam J. Dynamics of the HPA axis and inflammatory cytokines: insights from mathematical modeling. Comput. Biol. Med. 2015, 67:1-12.
19. Menzies V., Lyon D.E., Elswick R.K., Montpetit A.J., McCain N.L. Psychoneuroimmunological relationships in women with fibromyalgia. Biol. Res. Nurs. 2013, 15(2):219-225.
20. Monterde S., Salvat I., Montull S., Fernández-Ballart J. Validation of the Spanish version of the fibromyalgia impact questionnaire. Rev. Esp. Reumatol. 2004, 31(09):507-513.
21. Nugraha B., Korallus C., Kielstein H., Gutenbrunner C. CD3+CD56+natural killer T cells in fibromyalgia syndrome patients: association with the intensity of depression. Clin. Exp. Rheumatol. 2013, 31(6 Suppl. 79):S9-15.
22. Ortega E., Bote M.E., Giraldo E., Garcia J.J. Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patients. Scand. J. Med. Sci. Sports 2012, 22(1):104-112.
23. Rodriguez-Pinto I., Agmon-Levin N., Howard A., Shoenfeld Y. Fibromyalgia and cytokines. Immunol. Lett. 2014, 161(2):200-203.
24. Russell I.J., Mease P.J., Smith T.R., Kajdasz D.K., Wohlreich M.M., Detke M.J., et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008, 136(3):432-444.
25. Savino W., Mendes-da-Cruz D.A., Lepletier A., Dardenne M. Hormonal control of T-cell development in health and disease. Nat. Rev. Endocrinol. 2015.
26. Tak L.M., Cleare A.J., Ormel J., Manoharan A., Kok I.C., Wessely S., et al. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol. Psychol. 2011, 87(2):183-194.
27. Torgrimson-Ojerio B., Ross R.L., Dieckmann N.F., Avery S., Bennett R.M., Jones K.D., et al. Preliminary evidence of a blunted anti-inflammatory response to exhaustive exercise in fibromyalgia. J. Neuroimmunol. 2014, 277(1-2):160-167.
28. Uceyler N., Hauser W., Sommer C. Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet. Disord. 2011, 12:245.
29. Walsh N.P., Gleeson M., Shephard R.J., Gleeson M., Woods J.A., Bishop N.C., et al. Position statement. Part one: immune function and exercise. Exerc. Immunol. Rev. 2011, 17:6-63.
30. Wang H., Buchner M., Moser M.T., Daniel V., Schiltenwolf M. The role of IL-8 in patients with fibromyalgia: a prospective longitudinal study of 6months. Clin. J. Pain 2009, 25(1):1-4.
31. Wolfe F., Clauw D.J., Fitzcharles M.A., Goldenberg D.L., Katz R.S., Mease P., et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. (Hoboken) 2010, 62(5):600-610.
32. Xiao Y., Haynes W.L., Michalek J.E., Russell I.J. Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol. Int. 2013, 33(5):1259-1264.